Recombinant multi-species CREBBP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CREBBP protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is ubiquitously expressed and is involved in the transcriptional coactivation of many different transcription factors. First isolated as a nuclear protein that binds to cAMP-response element binding protein (CREB), this gene is now known to play critical roles in embryonic development, growth control, and homeostasis by coupling chromatin remodeling to transcription factor recognition. The protein encoded by this gene has intrinsic histone acetyltransferase activity and also acts as a scaffold to stabilize additional protein interactions with the transcription complex. This protein acetylates both histone and non-histone proteins. This protein shares regions of very high sequence similarity with protein p300 in its bromodomain, cysteine-histidine-rich regions, and histone acetyltransferase domain. Mutations in this gene cause Rubinstein-Taybi syndrome (RTS). Chromosomal translocations involving this gene have been associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]
The Alternative Names of target: CBP,CBP/p300,CREB-binding protein,CREBBP,Crebbp,Histone lysine acetyltransferase CREBBP,KAT3A,MKHK1,Protein lactyltransferas CREBBP,Protein-lysine acetyltransferase CREBBP,RSTS,RSTS1,RTS,hmm291030,p300/CBP
Go
to CREBBP products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T03634-Ag-1/ GM-Tg-hg-T03634-Ag-2 | Human CREBBP protein | Human |
| GM-Tg-rg-T03634-Ag-1/ GM-Tg-rg-T03634-Ag-2 | Rat CREBBP protein | Rat |
| GM-Tg-mg-T03634-Ag-1/ GM-Tg-mg-T03634-Ag-2 | Mouse CREBBP protein | Mouse |
| GM-Tg-cynog-T03634-Ag-1/ GM-Tg-cynog-T03634-Ag-2 | Cynomolgus/Rhesus macaque CREBBP protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T03634-Ag-1/ GM-Tg-felg-T03634-Ag-2 | Feline CREBBP protein | Feline |
| GM-Tg-cang-T03634-Ag-1/ GM-Tg-cang-T03634-Ag-2 | Canine CREBBP protein | Canine |
| GM-Tg-bovg-T03634-Ag-1/ GM-Tg-bovg-T03634-Ag-2 | Bovine CREBBP protein | Bovine |
| GM-Tg-equg-T03634-Ag-1/ GM-Tg-equg-T03634-Ag-2 | Equine CREBBP protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T03634-Ag-1/ GM-Tg-hg-T03634-Ag-2;
GM-Tg-rg-T03634-Ag-1/ GM-Tg-rg-T03634-Ag-2;
GM-Tg-mg-T03634-Ag-1/ GM-Tg-mg-T03634-Ag-2; GM-Tg-cynog-T03634-Ag-1/ GM-Tg-cynog-T03634-Ag-2; GM-Tg-felg-T03634-Ag-1/ GM-Tg-felg-T03634-Ag-2; GM-Tg-cang-T03634-Ag-1/ GM-Tg-cang-T03634-Ag-2; GM-Tg-bovg-T03634-Ag-1/ GM-Tg-bovg-T03634-Ag-2; GM-Tg-equg-T03634-Ag-1/ GM-Tg-equg-T03634-Ag-2 |
| Products Name | CREBBP protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | CREBBP |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CREBBP protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.